Ads
related to: newest advanced prostate cancer treatments pros and cons- Support Your Loved Ones
Explore Resources And Get Guidance
On How To Care For Someone With PC.
- Understand Your Results
Learn About Tests And Scans Used
To Diagnose And Monitor PC.
- Cancer Progression
Understand The Different Kinds Of
Prostate Cancer & Its Progression.
- Patient Story Videos
Watch Real Stories Of Patients
Who Have Battled Prostate Cancer.
- Support Your Loved Ones
Search results
Results from the WOW.Com Content Network
An innovative new drug being trialled to tackle certain cancers could also benefit patients with advanced prostate cancer whose treatment has stopped working, according to scientists.
New Advancements in Prostate Cancer Treatment RESEARCHERS CONTINUE TO look for new treatments for prostate cancer, and a number of “exciting developments” are in the works, Dr. Siddiqui says.
Palliative care for advanced-stage prostate cancer focuses on extending life and relieving the symptoms of metastatic disease. As noted above, abiraterone is showing some promise in treating advanced-stage prostate cancer. It causes a dramatic reduction in PSA levels and tumor sizes in aggressive advanced-stage prostate cancer for 70% of patients.
Androgen deprivation therapy (ADT), also called androgen ablation therapy or androgen suppression therapy, is an antihormone therapy whose main use is in treating prostate cancer. Prostate cancer cells usually require androgen hormones, such as testosterone, to grow. ADT reduces the levels of androgen hormones, with drugs or surgery, to prevent ...
As of August 2014, a clinical trial administering sipuleucel-T in conjunction with ipilimumab (Yervoy) was tracking subjects but no longer enrolling new subjects; the trial evaluates the clinical safety and anti-cancer effects (quantified in PSA, radiographic and T cell response) of the combination therapy in patients with advanced prostate cancer.
Most alternative cancer treatments have not been tested in proper clinical trials. Among studies that have been published, the quality is often poor. A 2006 review of 196 clinical trials that studied unconventional cancer treatments found a lack of early-phase testing, little rationale for dosing regimens, and poor statistical analyses. [11]
Ads
related to: newest advanced prostate cancer treatments pros and cons